Advances in the Development of Antiviral Compounds for Rotavirus Infections
Group A rotaviruses (RVAs) are the major cause of severe acute gastroenteritis (AGE) in children under 5 years of age, annually resulting in nearly 130,000 deaths worldwide. Social conditions in developing countries that contribute to decreased oral rehydration and vaccine efficacy and the lack of...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
American Society for Microbiology
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/c4f9acf65eb1487e8b511935630f3f91 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Group A rotaviruses (RVAs) are the major cause of severe acute gastroenteritis (AGE) in children under 5 years of age, annually resulting in nearly 130,000 deaths worldwide. Social conditions in developing countries that contribute to decreased oral rehydration and vaccine efficacy and the lack of approved antiviral drugs position RVA as a global health concern. |
|---|